LBPH Longboard Pharmaceuticals
- 36.080
- +0.540+1.52%
- 36.080
- 0.0000.00%
Longboard Pharmaceuticals News
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lind Kevin Robert
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kaye Randall
Longboard Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Longboard Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Longboard Pharmaceuticals | 8-K: Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
Longboard Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Viking Global Investors LP(5.2%),Viking Global Opportunities Parent GP LLC(5.2%), etc.
Longboard Pharmaceuticals | 8-K: Current report
Longboard Pharmaceuticals | 8-K: Current report
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SEKHRI PAUL J
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SCHNEIDER PHILLIP M
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lynch Casey
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Le Goff Corinne
Longboard Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aurentz Vincent
Longboard Pharmaceuticals | 8-K: Current report
Longboard Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
Longboard Pharmaceuticals | 8-K: Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Longboard Pharmaceuticals | 8-K: Current report
Longboard Pharmaceuticals | ARS: Annual Report to Security Holders
Longboard Pharmaceuticals | DEFA14A: Others
Longboard Pharmaceuticals | DEF 14A: Definitive information statements
Analysis
Price Target
No Data
